参考文献

1. 汪复，朱德妹，胡付品，等.2013年中国CHINET细菌耐药性监测.中国感染与化疗杂志，2014，14（5）：365-374.

2. Jones RN，Castanheira M，Hu B，et al.Update of contemporary antimicrobial resistance rates across China：reference testing results for 12 medical centers（2011）.Diagn Microbiol Infect Dis，2013，77（3）：258-266.

3. Zhuo C，Li XQ，Zong ZY，et al.Epidemic plasmid carrying bla （CTX-M-15）in Klebsiella penumoniae in China.PLoS One，2013，8（1）:e52222.

4. Hawser SP，Bouchillon SK，Hoban DJ，et al.Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe：results of the 2008 Study for Monitoring Antimicrobial Resistance Trends（SMART）.Antimicrob Agents Chemother，2010，54（7）：3043-3046.

5. Xia S，Fan X，Huang Z，et al.Dominance of CTX-M-type extended-spectrum β-lactamase（ESBL）-producing Escherichia coli isolated from patients with community-onset and hospitalonset infection in China.PLoS One，2014，9（7）：e100707.

6. Tamma PD，Girdwood SC，Gopaul R，et al.The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.Clin Infect Dis，2013，57（6）：781-788.

7. 孙宏莉，宁永忠，廖康，等.全国10所教学医院产ESBLs和质粒AmpC酶大肠埃希菌及肺炎克雷伯菌的研究.中国感染与化疗杂志，2007，7（5）：323-329.

8. Wei ZQ，Du XX，Yu YS，et al.Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.Antimicrob Agents Chemother，2007，51（2）:763-765.

9. Qin S，Fu Y，Zhang Q，et al.High incidence and endemic spread of NDM-1- positive Enterobacteriaceae in Henan Province，China. Antimicrob Agents Chemother，2014，58（8）：4275-4282.

10. Munoz-Price LS，Weinstein RA.Acinetobacter infection.N Engl J Med，2008，358（12）：1271-1281.

11. 李光辉，朱德妹，汪复，等.2011年中国CHINET血培养临床分离菌的分布及耐药性.中国感染与化疗杂志，2013，13（4）：241-247.

12. Yang YS，Lee YT，Huang TW，et al.Acinetobacter baumannii nosocomial pneumonia：is the outcome more favorable in nonventilated than ventilated patients？BMC Infect Dis，2013，13：142.

13. Jones RN.Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.Clin Infect Dis，2010，51（Suppl 1）:S81-87.

14. Breidenstein EB，de la Fuente-Núñez C，Hancock RE.Pseudomonas aeruginosa：all roads lead to resistance.Trends Microbiol，2011，19（8）:419-426.

15. Zhou H，Yang Q，Yu YS，et al.Clonal spread of imipenemresistant Acinetobacter baumannii among different cities of China.J Clin Microbiol，2007，45（12）：4054-4057.

16. Liebana E，Carattoli A，Coque TM，et al.Public health risks of enterobacterial isolates producing extended-spectrum β-lactamases or AmpC β-lactamases in food and food-producing animals：an EU perspective of epidemiology，analytical methods，risk factors，and control options.Clin Infect Dis，2013，56 （7）:1030-1037.

17. Munoz-Price LS，Poirel L，Bonomo RA，et al.Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis，2013，13（9）：785-796.

18. Cornaglia G，Giamarellou H，Rossolini GM.Metallo-β-lactamases：a last frontier for β-lactams？Lancet Infect Dis，2011，11（5）:381-393.

19. Bush K，Fisher JF.Epidemiological expansion，structural studies，and clinical challenges of new β-lactamases from gramnegative bacteria.Annu Rev Microbiol，2011，65:455-478.

20. Doi Y，Arakawa Y.16S ribosomal RNA methylation：emerging resistance mechanism against aminoglycosides.Clin Infect Dis，2007，45（1）:88-94.

21. Nikaido H，Pagès JM.Broad specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.FEMS Microbiol Rev，2012，36（2）:340-363.

（卓超　王辉）